Show simple item record

dc.contributor.authorWest, Catharine M L
dc.contributor.authorJones, Terry
dc.contributor.authorPrice, Patricia M
dc.date.accessioned2009-10-19T15:30:13Z
dc.date.available2009-10-19T15:30:13Z
dc.date.issued2004-06
dc.identifier.citationThe potential of positron-emission tomography to study anticancer-drug resistance. 2004, 4 (6):457-69 Nat. Rev. Canceren
dc.identifier.issn1474-175X
dc.identifier.pmid15170448
dc.identifier.doi10.1038/nrc1368
dc.identifier.urihttp://hdl.handle.net/10541/84405
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAntineoplastic Agents
dc.subject.meshDrug Resistance, Neoplasm
dc.subject.meshHumans
dc.subject.meshNeoplasms
dc.subject.meshTomography, Emission-Computed
dc.titleThe potential of positron-emission tomography to study anticancer-drug resistance.en
dc.typeArticleen
dc.contributor.departmentAcademic Department of Radiation Oncology and Manchester Molecular Imaging Centre, University of Manchester, Christie NHS Trust Hospital, Wilmslow Road, Manchester, M20 4BX, United Kingdom. catharine.west@man.ac.uken
dc.identifier.journalNature Reviews. Canceren


This item appears in the following Collection(s)

Show simple item record